BioFactura (United States)

Recent papers from BioFactura (United States)

1. Gamma-Irradiated Female Aedes aegypti Mosquitoes Exhibit Greater Susceptibility to Mayaro VirusAmerican Journal of Tropical Medicine and Hygiene · 2024
2. Pharmacokinetic Profiles of a Proposed Biosimilar Ustekinumab (BFI‐751): Results From a Randomized Phase 1 TrialClinical Pharmacology in Drug Development · 2023
3. Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer BiologyeLife · 2021
4. Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodiesPLoS ONE · 2021
5. Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonanceVaccine · 2020
6. Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic BovinesScientific Reports · 2020
7. Development of an antibody cocktail for treatment of Sudan virus infectionProceedings of the National Academy of Sciences · 2020
8. Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus diseasePLoS neglected tropical diseases · 2018
9. Enhanced expression of a biosimilar monoclonal antibody with a novel NS0 platformBiotechnology Progress · 2018
10. Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutationseLife · 2017
11. Lassa Fever in Post-Conflict Sierra LeoneSHILAP Revista de lepidopterología · 2014
12. Integrated biofabrication for electro‐addressed in‐film bioprocessingBiotechnology Journal · 2011
13. Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevanceVirology Journal · 2008